Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 295

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 295
---
 on this 19 day of May, 2025.

| REGENTIS BIOMATERIALS LTD. |                         |
| By:                        | /s/ Dr. Eli Hazum       |
|                            | Dr. Eli Hazum,          |
|                            | Chief Executive Officer |

Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature             
 /s/ Dr. Eli Hazum     
 Dr. Eli Hazum         |     | Title                                        
 Chief Executive Officer                      
 (Principal Executive Officer)                |     | Date         
 May 19, 2025 |
|:----------------------|:----|:---------------------------------------------|:----|:-------------|
| /s/ Arie Gordashnikov |     | Chief Financial Officer                      |     |              |
| Arie Gordashnikov     |     | -Principal Financial and Accounting Officer  |     | May 19, 2025 |
| *                     |     | Director, Chairman of the Board of Directors |     |              |
| Dr. Ehud Geller       |     |                                              |     | May 19, 2025 |
| *                     |     | Director                                     |     |              |
| Jeff Dykan            |     |                                              |     | May 19, 2025 |
| *                     |     | Director                                     |     |              |
| Keith Valentine       |     |                                              |     | May 19, 2025 |

| * /s/ Dr. Eli Hazum |
| Dr. Eli Hazum       |
| Attorney-in-fact    |

<div align='center'>II-9

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, the undersigned, Puglisi & Associates, the duly authorized representative in the United
States of Regentis Biomaterials Ltd., has signed this Registration Statement on this 19 day of May, 2025.

| Puglisi & Associates           |                   |
| Authorized U.S. Representative |                   |
| /s/                            
 Donald J. Puglisi              |                   |
| Name:                          | Donald J. Puglisi |
| Title:                         | Managing Director |

<div align='center'>II-10</div>